Ed Cadman
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Biochemical and Molecular Research 21
- Cancer therapeutics and mechanisms 5
- Oncology 26
- Colorectal Cancer Treatments and Studies 12
- Cancer Treatment and Pharmacology 8
- Co-authors
- Robert Heimer (10 shared papers)Joseph R. Bertino (10 shared papers)Chris Benz (9 shared papers)Lynn Davis (1 shared paper)Robert L. Capizzi (2 shared papers)Christopher C. Benz (4 shared papers)Leonard R. Farber (8 shared papers)R.D. Armstrong (5 shared papers)
- Journals
- Cancer (7 papers)Cancer Chemotherapy and Pharmacology (5 papers)Analytical Biochemistry (2 papers)Biochemical and Biophysical Research Communications (2 papers)Biochemical Pharmacology (2 papers)
- Partner nations
- United States
In The Last Decade
Ed Cadman
59 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 91
- Oncology 700
- Pathology and Forensic Medicine 352
- Genetics 197
- Hematology 178
- Cancer Research 164
Countries citing papers authored by Ed Cadman
This map shows the geographic impact of Ed Cadman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ed Cadman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ed Cadman more than expected).
Fields of papers citing papers by Ed Cadman
This network shows the impact of papers produced by Ed Cadman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ed Cadman. The network helps show where Ed Cadman may publish in the future.
Co-authors
The 25 scholars most cited alongside Ed Cadman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1979 | 205 | |
| 2 | 1977 | 191 | |
| 3 | 1981 | 123 | |
| 4 | Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8. | 1981 | 93 |
| 5 | 1988 | 82 | |
| 6 | 1985 | 81 | |
| 7 | 1985 | 62 | |
| 8 | 1977 | 61 | |
| 9 | Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure. | 1980 | 55 |
| 10 | 1979 | 48 | |
| 11 | Optimal schedule of methotrexate and 5-fluorouracil in human breast cancer. | 1982 | 45 |
| 12 | 1982 | 43 | |
| 13 | Tamoxifen and 5-fluorouracil in breast cancer: cytotoxic synergism in vitro. | 1983 | 42 |
| 14 | 5'-Deoxy-5-fluorouridine selective toxicity for human tumor cells compared to human bone marrow. | 1983 | 41 |
| 15 | 1988 | 39 | |
| 16 | Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity. | 1983 | 38 |
| 17 | 1981 | 37 | |
| 18 | Combination therapy for diffuse histiocytic lymphoma that includes antimetabolites. | 1977 | 31 |
| 19 | Pyrazofurin enhancement of 5-azacytidine antitumor activity in L5178Y and human leukemia cells. | 1978 | 29 |
| 20 | 1981 | 27 |
About Ed Cadman
Ed Cadman is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Infectious Diseases, having authored 61 papers that have together received 1.8k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (21 papers), Colorectal Cancer Treatments and Studies (12 papers), Acute Lymphoblastic Leukemia research (8 papers), Cancer Treatment and Pharmacology (8 papers), Lymphoma Diagnosis and Treatment (8 papers), Lung Cancer Treatments and Mutations (8 papers), HIV/AIDS drug development and treatment (7 papers) and Cancer therapeutics and mechanisms (5 papers). The work is most often cited by research in Oncology (700 citations), Pathology and Forensic Medicine (352 citations), Genetics (197 citations), Hematology (178 citations) and Cancer Research (164 citations). Ed Cadman has collaborated with scholars based in United States. Frequent co-authors include Robert Heimer, Joseph R. Bertino, Chris Benz, Lynn Davis, Robert L. Capizzi, Christopher C. Benz, Leonard R. Farber, R.D. Armstrong, Frank J. Rauscher and Walter B. Lundberg. Their work appears in journals such as Cancer, Cancer Chemotherapy and Pharmacology, Analytical Biochemistry, Biochemical and Biophysical Research Communications and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.